LOS ANGELES, CA, November 15, 2011 (Press-News.org) With the launch of TODD|Co:, Todd Rosholt combines his 20 years of experience in the event industry with his vast network of strategic thinkers and solution providers to offer his clients a new model for driving success. "We approach every project and client from the same starting point: What if you did things differently? What if you didn't make assumptions? What if you tried something new? What if you were willing to fail to succeed? "When you throw those barriers away, a whole universe of potential opens up," said Rosholt. "Success for live events is a multi-faceted value proposition, which means there are many paths to revenue growth."
TODD|Co: examines the multiple sides of an event's value proposition using its own four phase "WOW Process" to identify, evaluate and design success opportunities and to deliver solutions for driving success that are both actionable and measurable.
TODD|Co: is a solutions oriented firm that delivers superior results based on the alchemy of years of experience mixed with insatiable curiosity. Part consultant, part analyst, part guru, TODD|Co: is pioneering a new success model through innovations such as risk-sharing implementations and non-traditional partnerships. To learn more about how TODD|Co: works, visit http://www.toddrosholt.com
TODD|Co:, An Event Innovation Firm, Launches in Los Angeles
TODD|Co:, a new firm offering business growth services, has opened in Los Angeles. Founded by Todd Rosholt, TODD|Co: focuses on helping live events drive success and grow their business through a unique system of insight and innovation.
2011-11-15
ELSE PRESS RELEASES FROM THIS DATE:
Results triple researchers' projections with use of adult stem cells for heart failure
2011-11-15
ORLANDO, Fla. – Patients suffering from heart failure due to a previous myocardial infarction showed an average of 12 percent improvement one year following an investigative treatment that involved infusing them with their own stem cells. The results triple the 4 percent improvement average the researchers projected for the Phase I trial.
Results of the trial are published today (Nov. 14) in The Lancet and concurrently presented at the American Heart Association Scientific Sessions in Orlando, Fla. They are the first report of administering subjects' own cardiac stem ...
Izzycue Wins Supply Bid for Organic Canola Mayo Production for Whole Foods Market Mid-Atlantic Regional Prepared Foods Kitchen.
2011-11-15
Izzycue has launched a proprietary line of USDA Certified Organic canola mayonnaise for Whole Foods Market, Inc. (WFMI) in the Mid-Atlantic Regional prepared foods kitchen.
This new line of mayonnaise is made with a healthier non-GMO expeller-pressed canola oil and packed in a bulk format.
"Today we reaffirmed our company's mission of catering to companies whose CSRs are aligned to that of ours," says Kenneth H. Tan, the company's Founder and CEO. "Producing good food with good ingredients is a strong CSR," continues Kenneth.
In the food service ...
Study finds tropical areas aren't the only source of seasonal flu
2011-11-15
DURHAM, N.C. and SINGAPORE – A commonly held theory says that flu virus originates every year in Southeast and Eastern Asia, making this region the source of seasonal flu epidemics in other parts of the world.
However, researchers at Duke-NUS Graduate Medical School in Singapore have found that influenza virus in tropical areas isn't the only global source of flu epidemics. The international team of scientists involved in the work found that any one of the urban centers they studied could act as a source for a flu epidemic in any other locality.
"We found that these ...
Teambox Goes Mobile and Rolls Out Preview of v4 Beta!
2011-11-15
The long awaited Teambox Apps for iPhone and iPad are now available on the App Store. Now, more than 100.000 organizations around the world can get things done anywhere, from their couch, while traveling or taking notes while in a meeting with others.
"Since we launched Teambox we knew clearly the web would not be the only platform for our users. The new mobile environment in which we all live offers endless possibilities - and we want our users to be able to go mobile with their projects, too!" says Pablo Villalba, Teambox founder.
Users of other mobile ...
New method for producing precursor of neurons, bone and other important tissues from stem cells
2011-11-15
Athens, Ga. – In principle, stem cells offer scientists the opportunity to create specific cell types—such as nerve or heart cells—to replace tissues damaged by age or disease. In reality, coaxing stem cells to become the desired cell type can be challenging, to say the least.
In a paper published this week in the journal Proceedings of the National Academy of Sciences, however, scientists at the University of Georgia describe a method that—in a single step—directs undifferentiated, or pluripotent, stem cells to become neural crest cells, which are the precursors of bone ...
Radioshow With Dw. Dunphy Now On Asbury Music
2011-11-15
When it was announced that New Jersey's The Penguin internet radio station was changing names and tailoring its format to a more-Jersey-centric playlist, many asked how that would affect the stalwart programs that were hosted by The Penguin; in specific, Radioshow With Dw. Dunphy.
The answer, according to Dunphy: "Not much!" The series, a longtime fixture of The Penguin mixed Dunphy's radically eclectic musical tastes with an anarchic freeform radio aesthetic. "There were days when the D.J. was given free reign to play whatever he or she wanted," ...
Better understanding of neurologic defects improves post-cardiac-arrest discharge
2011-11-15
Delay in initiation of therapeutic hypothermia and delay in return of spontaneous circulation (ROSC), evidenced by a palpable pulse or a measurable blood pressure, were both associated with poor neurologic outcomes in post cardiac arrest patients, according to a study being presented Nov. 14 at the at the American Heart Association (AHA) scientific sessions in Orlando, Fla. Also, caregivers who have an appropriate understanding of the patient's post cardiac arrest neurologic state could ensure better patient management at discharge.
The researchers were seeking to determine ...
Hypothermia remains effective in cardiac arrest patients with preexisting cardiomyopathy
2011-11-15
Cardiomyopathy is common among cardiac arrest survivors. The survival and neuroprotective benefits of therapeutic hypothermia is similar in patients with preexisting cardiomyopathy, compared with those patients without cardiomyopathy, according to a scientific poster being presented Nov. 14 at the at the American Heart Association (AHA) scientific sessions in Orlando, Fla. Therefore, the researchers recommended the use of therapeutic hypothermia in patients with the preexisting condition.
"While it is well established that therapeutic hypothermia is neuroprotective and ...
Tom Riquier, CFP , CLU Attends the Retirement Income Symposium
2011-11-15
Thomas T. Riquier, CFP , CLU, President of The Retirement Financial Center in Danvers, recently attended the 4th Annual Retirement Income Symposium in Boston.
This intensive 2-day conference featured discussions by leading industry experts about potential strategies to optimize retirement income planning. The topics covered were especially relevant as the first wave of baby boomers are reaching retirement age while our nation is recovering from financial instability. Speakers discussed issues ranging from Retirement Income as a National Priority to Retirement Readiness. ...
Do you really know what you want in a partner?
2011-11-15
EVANSTON, Ill. --- So you're flocking to online dating sites with a wish list of ideal traits that you desire in a mate. Not so fast!
Once you actually meet a potential dating partner, those ideals are likely to fall by the wayside, according to new research from Northwestern University and Texas A&M University.
People liked potential partners that matched their ideals more than those that mismatched their ideals when they examined written descriptions of potential partners, but those same ideals didn't matter once they actually met in person, according to a new study ...
LAST 30 PRESS RELEASES:
First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer
Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial
Higher blood pressure in childhood linked to earlier death from heart disease in adulthood
AI helped older adults report accurate blood pressure readings at home
High blood pressure in childhood and premature cardiovascular disease mortality
Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations
Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC
Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy
FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC
Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study
New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients
Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds
COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC
CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC
Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital
New medication lowered hard-to-control high blood pressure in people with chronic kidney disease
Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment
New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment
Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor
Study prompts new theory of human-machine communication
New method calculates rate of gene expression to understand cell fate
Researchers quantify rate of essential evolutionary process in the ocean
Innovation Crossroads companies join forces, awarded U.S. Air Force contract
Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations
Pioneering advances in in vivo CAR T cell production
Natural medicines target tumor vascular microenvironment to inhibit cancer growth
Coral-inspired pill offers a new window into the hidden world of the gut
nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high
When getting a job makes you go hungry
Good vibrations could revolutionize assisted reproductive technology
[Press-News.org] TODD|Co:, An Event Innovation Firm, Launches in Los AngelesTODD|Co:, a new firm offering business growth services, has opened in Los Angeles. Founded by Todd Rosholt, TODD|Co: focuses on helping live events drive success and grow their business through a unique system of insight and innovation.